Cancer patients miss out on cardioprotective therapies

Cardioprotective therapies such as statins and antiplatelet agents are underutilised in patients with cancer, an Australian study has shown. A retrospective review of medical records of 320 patients admitted to the cardiology unit at John Hunter Hospital in 2018 and 2019 found that patients with a history of cancer who had an indication for cardioprotective ...

Already a member?

Login to keep reading.

© 2021 the limbic